ZAVESCA 100 mg, capsules 84 capsules
Active ingredients: Miglustat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule84 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZAVESCA 100 mg, gélules
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) thermoformée(s) aluminium-ACLAR de 21 gélule(s)
- Marketing authorisation holder
- ADVANZ PHARMA LIMITED
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jan 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65793983CIP75641169CIP133400956411696Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIGLUSTATgélule | 100 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.